These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 23995863

  • 1. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 3. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 5. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY, Yu X, Chen XM, Lu F, Chen N, Li XW, Tang CS, Chan TM.
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [Abstract] [Full Text] [Related]

  • 6. Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis.
    Lanata CM, Mahmood T, Fine DM, Petri M.
    Lupus; 2010 Jul; 19(8):935-40. PubMed ID: 20388722
    [Abstract] [Full Text] [Related]

  • 7. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H, Hiromura K, Takahashi S, Mishima K, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Kuroiwa T, Nojima Y.
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [Abstract] [Full Text] [Related]

  • 9. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L, Y T, X P, L W, H W, Z S, H Z, Z H, MMF in Induction Therapy for Active Lupus Nephritis in Mainland China Study Group.
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [Abstract] [Full Text] [Related]

  • 10. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Jul; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC, Tong KH, To CH, Siu YP, Au TC.
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [Abstract] [Full Text] [Related]

  • 12. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH, Song GG.
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of mycophenolate mofetil in Japanese patients with systemic lupus erythematosus.
    Kawazoe M, Kaneko K, Yamada Z, Masuoka S, Mizutani S, Yamada S, Shikano K, Sato H, Kaburaki M, Muraoka S, Kawai S, Nanki T.
    Clin Rheumatol; 2019 Jun; 38(6):1571-1578. PubMed ID: 30778862
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.
    Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, Shen P, Chen N.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study.
    Park DJ, Kang JH, Lee KE, Bae SC, Chung WT, Choe JY, Jung SY, Kim YS, Lee HS, Lee J, Lee YA, Park SH, Park YJ, Suh CH, Yoo DH, Lee SS.
    Clin Exp Rheumatol; 2019 Apr; 37(1):89-96. PubMed ID: 29998829
    [Abstract] [Full Text] [Related]

  • 16. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J, Torres-Salido MT, Medrano AS, Tarrés MV, Ordi-Ros J.
    Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
    [Abstract] [Full Text] [Related]

  • 18. The efficacy of low-dose mycophenolate mofetil for treatment of lupus nephritis in Taiwanese patients with systemic lupus erythematosus.
    Weng MY, Weng CT, Liu MF.
    Clin Rheumatol; 2010 Jul; 29(7):771-5. PubMed ID: 20195879
    [Abstract] [Full Text] [Related]

  • 19. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 20. Current therapies for lupus nephritis in an ethnically heterogeneous cohort.
    Rivera TL, Belmont HM, Malani S, Latorre M, Benton L, Weisstuch J, Barisoni L, Tseng CE, Izmirly PM, Buyon JP, Askanase AD.
    J Rheumatol; 2009 Feb; 36(2):298-305. PubMed ID: 19040310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.